Page last updated: 2024-10-24

regulation of T cell cytokine production

Definition

Target type: biologicalprocess

Any process that modulates the frequency, rate, or extent of T cell cytokine production. [GOC:add]

T cell cytokine production is a complex process regulated by a intricate network of intracellular signaling pathways, transcription factors, and epigenetic modifications. The key elements involved in this process are:

**1. Antigen Recognition and TCR Signaling:**
- T cell activation begins with the recognition of specific antigens presented by antigen-presenting cells (APCs) through the T cell receptor (TCR).
- This interaction initiates a cascade of signaling events through the TCR complex, leading to the activation of downstream kinases, such as ZAP-70, Lck, and Fyn.
- These kinases phosphorylate adaptor proteins, like LAT and SLP-76, which act as scaffolding proteins and recruit other signaling molecules.

**2. Calcium Signaling and NFAT Activation:**
- TCR signaling triggers an influx of calcium ions (Ca2+) into the T cell cytoplasm, activating the calcineurin phosphatase.
- Calcineurin dephosphorylates the nuclear factor of activated T cells (NFAT), allowing it to translocate to the nucleus.
- NFAT acts as a transcription factor, binding to specific DNA sequences in the promoters of cytokine genes and promoting their expression.

**3. MAPK Signaling and AP-1 Activation:**
- TCR signaling also activates the mitogen-activated protein kinase (MAPK) pathway, involving kinases like ERK, JNK, and p38.
- MAPKs phosphorylate transcription factors, including members of the activator protein-1 (AP-1) family (c-Fos, c-Jun).
- AP-1, together with NFAT, forms a complex that further enhances the transcription of cytokine genes.

**4. Other Transcription Factors and Signaling Pathways:**
- In addition to NFAT and AP-1, several other transcription factors, like STATs (signal transducer and activator of transcription), IRF (interferon regulatory factor), and NF-κB (nuclear factor-κB), contribute to the regulation of cytokine gene expression.
- These factors are activated by various signaling pathways, including cytokine receptors, Toll-like receptors, and other cellular stimuli.

**5. Epigenetic Modifications:**
- Epigenetic modifications, such as histone acetylation and methylation, play a critical role in regulating cytokine gene expression.
- These modifications can influence the accessibility of cytokine gene promoters to transcription factors, thereby affecting gene expression levels.

**6. Cytokine Feedback Loops:**
- Cytokines produced by T cells can act on themselves or other immune cells, forming positive or negative feedback loops.
- For example, IL-2, a cytokine produced by T cells, can enhance T cell proliferation and cytokine production. Conversely, IL-10 can suppress T cell activation and cytokine production.

**7. Microenvironment and Immune Context:**
- The microenvironment and immune context in which T cells reside can significantly influence their cytokine production.
- Factors like the presence of specific antigens, the type of APCs, and the inflammatory milieu can all contribute to shaping the cytokine profile of T cells.

**8. Differentiation and Polarization of T cells:**
- T cells can differentiate into distinct subsets with specific cytokine profiles.
- For instance, Th1 cells primarily produce IFN-γ, while Th2 cells produce IL-4 and IL-5.
- The differentiation of T cells into specific subsets is influenced by the nature of the antigen encountered, the cytokines present in the microenvironment, and the expression of specific transcription factors.

**9. Regulation of Cytokine Expression at the mRNA and Protein Levels:**
- The expression of cytokine genes can be regulated at the mRNA level through processes like mRNA stability and translation.
- Cytokine production can also be controlled at the protein level by mechanisms like protein processing, secretion, and degradation.

In summary, the regulation of T cell cytokine production is a multi-layered process involving a complex interplay of signaling pathways, transcription factors, epigenetic modifications, and environmental cues. This intricate regulatory network ensures that T cell responses are appropriately tailored to specific immune challenges.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Transient receptor potential cation channel subfamily M member 4A transient receptor potential cation channel subfamily M member 4 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8TD43]Homo sapiens (human)
C-C chemokine receptor type 2A C-C chemokine receptor type 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P41597]Homo sapiens (human)

Compounds (20)

CompoundDefinitionClassesRoles
amiodaroneamiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
1-benzofurans;
aromatic ketone;
organoiodine compound;
tertiary amino compound
cardiovascular drug
disulfiramorganic disulfide;
organosulfur acaricide
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
EC 3.1.1.1 (carboxylesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
ferroptosis inducer;
fungicide;
NF-kappaB inhibitor
fasudilfasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.

fasudil: intracellular calcium antagonist; structure in first source
isoquinolines;
N-sulfonyldiazepane
antihypertensive agent;
calcium channel blocker;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
geroprotector;
neuroprotective agent;
nootropic agent;
vasodilator agent
nifedipineNifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.C-nitro compound;
dihydropyridine;
methyl ester
calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent
dibenzothiazyl disulfidedibenzothiazol-2-yl disulfide : An organic disulfide resulting from the formal oxidative coupling of the thiol groups of two molecules of 1,3-benzothiazole-2-thiol. It is used as an accelerator in the rubber industry.

dibenzothiazyl disulfide: vulcanizing accelerant
benzothiazoles;
organic disulfide
allergen
9-phenanthrol9-phenanthrol : A phenanthrol that is phenanthrene in which a hydrogen attached to a carbon in the central ring has been replaced by a hydroxy group.

9-phenanthrol: an inhibitor of AMP-dependent protein kinase catalytic subunit; structure in first source
phenanthrolTRPM4 channel inhibitor
1-naphthylisothiocyanate1-Naphthylisothiocyanate: A tool for the study of liver damage which causes bile stasis and hyperbilirubinemia acutely and bile duct hyperplasia and biliary cirrhosis chronically, with changes in hepatocyte function. It may cause skin and kidney damage.isothiocyanateinsecticide
plerixaforplerixafor : An azamacrocycle consisting of two cyclam rings connected by a 1,4-phenylenebis(methylene) linker. It is a CXCR4 chemokine receptor antagonist and a hematopoietic stem cell mobilizer. It is used in combination with grulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the perpheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma and multiple myeloma.

plerixafor: a bicyclam derivate, highly potent & selective inhibitor of HIV-1 & HIV-2
azacycloalkane;
azamacrocycle;
benzenes;
crown amine;
secondary amino compound;
tertiary amino compound
anti-HIV agent;
antineoplastic agent;
C-X-C chemokine receptor type 4 antagonist;
immunological adjuvant
rosiglitazoneaminopyridine;
thiazolidinediones
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
insulin-sensitizing drug
fasudil hydrochloridefasudil hydrochloride : A hydrochloride obtained by reaction of fasudil with one equivalent of hydrochloric acid.hydrochlorideantihypertensive agent;
calcium channel blocker;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
neuroprotective agent;
nootropic agent;
vasodilator agent
tak 779
bay 11-7085BAY11-7085 : A sulfone that is benzene substituted by [(E)-2-cyanoethenyl]sulfonyl and tert-butyl groups at position 1 and 4, respectively. It is an irreversible inhibitor of IkappaB-alpha phosphorylation in cells (IC50 = 10 muM) and prevents the activation of NF-kappaB.benzenes;
nitrile;
sulfone
anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
ferroptosis inducer;
NF-kappaB inhibitor
ucb 35625UCB 35625: J-113863 is the (trans)-isomer; structure in first source
rs 504393RS 504393: structure in first source1,3-oxazoles
incb3344INCB3344: potent and selective small molecule CCR2 chemokine receptor antagonist
amd 070mavorixafor: a derivative of AMD3100; a CXCR4 blockeraminoquinoline
cenicriviroccenicriviroc : A member of the class of benzazocines that is (5Z)-1,2,3,4-tetrahydro-1-benzazocine which is substituted by a 2-methylpropyl, N-{4-[(S)-(1-propyl-1H-imidazol-5-yl)methanesulfinyl]phenyl}carboxamide and 4-(2-butoxyethoxy)phenyl groups at positions 1, 5 and 8, respectively. It is a potent chemokine 2 and 5 receptor antagonist currently in development for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis (NASH).

cenicriviroc: an inhibitor of HIV-1
aromatic ether;
benzazocine;
diether;
imidazoles;
secondary carboxamide;
sulfoxide
anti-HIV agent;
anti-inflammatory agent;
antirheumatic drug;
chemokine receptor 2 antagonist;
chemokine receptor 5 antagonist
incb 3284INCB 3284: a CCR2 receptor antagonist
azd8309AZD8309: CXCR2 inhibitor
n-(carbamoylmethyl)-3-trifluoromethyl benzamido-4-chlorobenzyl 3-aminopyrrolidine